Regulating fatty acids in infant formula: Critical assessment of U.S. policies and practices

International Breastfeeding Journal

Volumn 9, Issue 1, 2014, Pages

  Kent, George ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

DHA; Docosahexaenoic acid; Fatty acids; Infant formula; Regulation

Indexed keywords

EID: 84892393350     PISSN: None     EISSN: 17464358     Source Type: Journal    
DOI: 10.1186/1746-4358-9-2     Document Type: Note

References (58)

1. Brody JE. Experts disagree on adding fatty acid to infant formula. New York Times 1996, [http://www.nytimes.com/1996/11/06/us/experts-disagree-on-adding-fatty-acid-to-infant-formula.html?pagewanted=all&src=pm].
2. Guidice C. Harmonisation: Mercosur gets to work on nutrition claims. EAS Strateg Advice: Europe 2012, [http://www.eas.eu/News_Item/921].
3. Astley M. ISO to cooperate with AOAC on infant formula standards. Nutra Ingredients.com 2012, [http://www.nutraingredients.com/Regulation/ISO-to-cooperate-with-AOAC-on-infant-formula-standards].
4. GOED Global Organization for EPA and DHA Omega-3. 2012, Website [http://www.goedomega3.com], GOED.
5. Codex Alimentarius Commission Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants. CODEX STAN 72-1981. (Formerly CAC/RS 72-1972. Adopted as a world-wide Standard 1981. Amended 1983, 1985, 1987. Revision 2007. Amended 2011). [http://www.codexalimentarius.org], Codex Alimentarius Commission.
6. U.S. Code of Federal Regulations Title 21 Part 107 (21CFR107). 2003, [http://www.access.gpo.gov/nara/cfr/waisidx_03/21cfr107_03.html], U.S. Code of Federal Regulations.
7. Gibson RA, Barclay D, Marshall H, Moulin J, Maire J-C, Makrides M. Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: a randomized controlled trial. Br J Nutr 2009, 101(11):1706-1713. 10.1017/S0007114508084080, 19134240.
8. Kent G. Regulating infant formula 2011, Amarillo, Texas: Hale Publishing.
9. U.S. Department of Health and Human Services Beech-Nut Corporation 2/22/10. Warning Letter 2010, Washington, DC: USDHHS: Food and Drug Administration, [http://www.fda.gov/iceci/enforcementactions/warningletters/ucm202834.htm], U.S. Department of Health and Human Services.
10. Vallaeys C. Replacing mother-imitating human breast milk in the laboratory 2008, Cornucopia, Wisconsin: Cornucopia Institute, [http://www.cornucopia.org/2008/01/replacing-mother-infant-formula-report/.
11. Living Wholesome Horizon organic gets flogged for bending its definition of 'organic'. Living Wholesome 2011, Living Wholesome.
12. Mitchell C. Challenge to horizon organic's DHA fortified milk. Food Safety News 2011, [http://www.foodsafetynews.com/2011/03/challenge-to-horizon-organics-new-dha-fortified-milk/].
13. U.S. Department of Health and Human Services Letter to Deputy Administrator of National Organic Program, USDA 2011, Washington, DC: USDHHS: Food and Drug Administration, U.S. Department of Health and Human Services.
14. Mullaney TJ. Martek sells its first product. Baltimore Sun 1994, [http://articles.baltimoresun.com/1994-12-14/business/1994348144_1_martek-biotechnology-baby-formulas].
15. Martek Infant benefits: DHA & ARA for infants health. Life's DHA: Healthy Brain, Eyes, Heart 2012, [http://www.lifesdha.com/dha-at-every-age/infants.aspx], Martek.
16. Qawasmi A, Landeros-Weisenberger A, Leckman JF, Bloch MH. Meta-analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition. Pediatrics 2012, 129(6).
17. Simmer K, Schulzke S, Patole S. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2008,
18. Simmer K, Patole S, Rao SC. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008,
19. Martek Infant development: the benefits of DHA and ARA during infancy. 2012, [http://www.lifesdha.com/clinical-research/infant-development.aspx], Martek.
20. Martek Martek to be the sole-source supplier of DHA and ARA for prodigy brand infant formula products in China 2009, Columbia, Maryland: Martek Biosciences Corporation, [http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aazU8t4zmy_M], Martek.
21. Martek Martek to be the sole source supplier of DHA and ARA for infant formulas produced by Grupo Ricap 2009, Columbia, Maryland: Martek Biosciences Corporation, [http://www.bloomberg.com/apps/news?pid=newsarchive&sid=a1SoDaBD_5t8], Martek.
22. Martek Martek signs sole-source supply agreement with Fonterra 2009, Columbia, Maryland: Martek Biosciences Corporation, [http://www.prweb.com/releases/dairy_fonterra/martek_biosciences/prweb3321614.htm], Martek.
23. Martek About life's DHA. 2012, [http://www.lifesdha.com/dha-at-every-age/infants.aspx], Martek.
24. Colombo J, Carlson SE. Is the measure the message: the BSID and nutritional interventions. Pediatrics 2012, 129(6):1166-1167. 10.1542/peds.2012-0934, 3362912, 22641756.
25. U.S. Department of Health and Human Services Questions & answers for consumers concerning infant formula 2013, Washington, DC: USDHHS Food and Drug Administration, http://www.fda.gov/Food/FoodborneIllnessContaminants/PeopleAtRisk/ucm108079.htm#16, U.S. Department of Health and Human Services.
26. Kent G. The nutritional adequacy of infant formula. Clin Lactation 2012, 3(1):21-25.
27. Nature's One Baby's Only Essentials® DHA Fatty Acid Supplement. 2012, [http://www.naturesone.com/dha/#], Nature's One.
28. Rowlands JC, Hoadley J. FDA perspective on health claims for food labels. Toxicology 2006, 221:35-43. 10.1016/j.tox.2005.10.023, 16480811.
29. Schneeman B. FDA's review of scientific evidence for health claims. J Nutr 2007, 137(2):493-494.
30. Reuterswärd AL. The new EC regulation on nutrition and health claims on foods. Scand J Food Nutr 2007, 51(3):100-106.
31. U.S. Department of Health and Human Services Is it really FDA approved?. 2012, USDHHS. Food and Drug Administration, [http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm047470.htm#formula], U.S. Department of Health and Human Services.
32. Chung CS, Yamini S, Trumbo PR. FDA's health claim review: whey-protein partially hydrolyzed infant formula and atopic dermatitis. Pediatrics 2012, 130:2.
33. U.S. Department of Health and Human Services Health claims meeting Significant Scientific Agreement (SSA). 2012, USDHHS. Food and Drug Administration, [http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm2006876.htm], U.S. Department of Health and Human Services.
34. Infant Formula Council Infant Formula Council (IFC) statement on DHA/ARA and infant formula. Infant Feeding & Nutrition 2010, [http://www.infantformula.org/news-room/press-releases-and-statements/infant-formula-and-dha/ara], Infant Formula Council.
35. U.S. Department of Health and Human Services Guidelines concerning notification and testing of infant formulas 2009, Washington, DC: USDHHS, Food and Drug Administration, Center for Food Safety and Applied Nutrition, [http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/InfantFormula/ucm169730.htm], U.S. Department of Health and Human Services.
36. U.S. Department of Health and Human Services Agency Response Letter, GRAS Notice No. GRN 000041 2001, Washington, DC: USDHHS, Food and Drug Administration, [http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm154126.htm], U.S. Department of Health and Human Services.
37. U.S. Department of Health and Human Services GRAS notice inventory. 2012, USDHHS. Food and Drug Administration, http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/default.htm, U.S. Department of Health and Human Services.
38. U.S. Department of Health and Human Services Guidance for industry: frequently asked questions about GRAS. 2004, USDHHS. Food and Drug Administration, [http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/IngredientsAdditivesGRASPackaging/ucm061846.htm], U.S. Department of Health and Human Services.
39. U.S. Department of Health and Human Services Agency Response Letter, GRAS Notice No. GRN 000080 2001, Washington, DC: USDHHS. Food and Drug Administration, [http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm154201.htm], U.S. Department of Health and Human Services.
40. Vallaeys C. DHA and ARA in infant formula: dangerous and unnecessary-synthetic additives have no place in infant foods 2012, Cornucopia, Wisconsin: Cornucopia Institute, [http://cornucopia.org/DHA/DHA-Update-2010.pdf].
41. Cornucopia Safety concerns: inadequate safety testing of Martek's DHA and ARA 2012, Cornucopia, Wisconsin: Cornucopia Institute, [http://www.cornucopia.org/dha-safety-concerns/], Cornucopia.
42. Cornucopia Official adverse reaction reports filed with the Food and Drug Administration 2012, Cornucopia, Wisconsin: Cornucopia Institute, [http://cornucopia.org/DHA/AdverseReactionReports.pdf], Cornucopia.
43. INFACT Canada Fools gold: recommendation: strong buy. INFACT Canada: Spring 1997 Newsletter: Breastfeeding Protection: Code Watch 1997, [http://www.infactcanada.ca/codewach.htm], INFACT Canada.
44. Neuberger Z. WIC food package should be based on science: foods with new functional ingredients should be provided only if they deliver health or nutritional benefits 2010, Washington, DC: Center on Budget and Policy Priorities, [http://www.cbpp.org/files/6-4-10fa.pdf].
45. Neuberger Z. Podcast: new ingredients raising costs for " WIC" program 2010, Washington, DC: Center on Budget and Policy Priorities, [http://www.cbpp.org/cms/index.cfm?fa=view&id=3213].
46. Minchin MK. Milk Matters: Immune Disorder and Infant Feeding. Alma Publications 2014, in press.
47. U.S. Federal Trade Commission FTC warns marketers of children's omega-3 fatty acid supplements that claims about brain and vision benefits may be deceptive 2010, Washington, DC: USFTC, [http://www.ftc.gov/opa/2010/02/omega.shtm], U.S. Federal Trade Commission.
48. U.S. Federal Trade Commission FTC approves final order settling charges that marketer of children's vitamins made deceptive claims about DHA and brain and eye development 2011, Washington, DC: USFTC, [http://www.ftc.gov/opa/2011/03/nbty.shtm], U.S. Federal Trade Commission.
49. U.S. Department of Health and Human Services Draft guidance for industry: frequently asked questions about medical foods 2011, USDHHS. Food and Drug Administration, [http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/MedicalFoods/ucm054048.htm#q1], U.S. Department of Health and Human Services.
50. Collier R. Squabble over risks of probiotics infant formula. Can Med Assoc J 2011, 181(3-4):E46-E47.
51. Mugambi M, Musekiwa A, Lombard M, Young T, Blaauw R. Probiotics, prebiotics infant formula use in preterm or low birth weight infants: a systematic review. Nutr J 2012, 11(58).
52. Probiotic Safety of probiotic products. Probiotic.org 2011, [http://www.probiotic.org/safety-of-probiotics.htm], Probiotic.
53. Shafai T. Routine supplement of prebiotics and probiotics to newborn infants are not recommended [Letter]. Pediatrics 2009, 123:e543-e544. 10.1542/peds.2008-3557, 19254990.
54. Yu VY. Scientific rationale and benefits of nucleotide supplementation of infant formula. J Paediatr Child Health 2002, 38(6):543-549. 10.1046/j.1440-1754.2002.00056.x, 12410863.
55. Parker L, Green R. Why doesn't baby formula list sugar content?. Target 5 2012, [http://www.nbcchicago.com/investigations/series/target-5/target-5-sugar-baby-formula-139339308.html].
56. UBIC Ingredients for the world infant formula market. UBIC Consulting 2013, [http://www.ubic-consulting.com/template/fs/documents/Nutraceuticals/Ingredients-in-the-world-infant-formula-market.pdf], UBIC.
57. Renub Research China baby food & drink market analysis and forecast to 2015. 2012, [http://www.marketresearch.com/Renub-Research-v3619/China-Baby-Food-Drink-Forecast-7086732/], Renub Research.
58. Montague-Jones G. Martek signs omega-3,-6 supply deal with Fonterra. Dairy Reporter.com 2009, [http://www.dairyreporter.com/Financial/Martek-signs-omega-3-6-supply-deal-with-Fonterra].